|
|
Develops human pharmaceuticals and agrochemicals
Celgene Corp. is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation.
Its targeting areas include intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies.
The company’s products include Revlimid, Vidaza, Thalomid, Pomalyst/Imnovid, Abraxane, and Istodax.
Celgene was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.
Number of employees : 7 132 persons. |
|
|
PLEASE FIND THE LINK BELOW FOR THE ACCESS:
CELG Equity Report CELG Equity Report
GOOD DAY!
Tinge Research 